HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Market For OTC COVID-19 Tests Transitions From Unmet Demand To Multiple Choices

Executive Summary

Abbott’s’s distribution of its BinaxNOW COVID-19 Ag Self Test to US retailers increases to three the number of OTC tests for the virus that CVS offers, along with Ellume’s and Labcorp’s test kits also available under EUAs granted by FDA.

You may also be interested in...



Herbal Sprays, Nasal Swabs Latest Additions On List Of Fraudulent COVID Cures Offered In US

“Germaphobe’s Delight Spray” was “re-vamped … to better meet the challenges of COVID-19,” Fopo Jordan’s Crossing Herbal claimed. Halodine LLC claimed its nasal sanitizer “kills SARS-CoV-2 (the virus that causes COVID-19) in less than 15 seconds.”

COVID-19 Test Kit’s Use Of US FDA Logo With ‘Clinical Trial Number’ Fails Regulatory Test

Anytime COVID Test marketed home-use test without FDA approval or EUA and promoted it with an FDA logo and a “clinical trial number.” Warning letter says “your presentation conveys the misimpression that the product has been approved, cleared, authorized, endorsed or otherwise evaluated by FDA.”

OTC COVID-19 Tests Have Abbott Seeing Continuing Demand For At-Home Diagnostics

“We see this is a as a significant opportunity, and quite frankly, a trend that's been happening overseas and is kind of now happening here in the US,” says Abbott Labs CEO Robert Ford.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS151241

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel